netFormulary
 Report : A-Z CDF items in Formulary 18/01/2021 13:38:34
[Back]
 
Section Status CDF Name
08.03.04.02 Formulary Cancer Drugs Fund Abiraterone Zytiga®
08.02.03 Formulary Cancer Drugs Fund Atezolizumab Tecentriq®
08.02.04 Formulary Cancer Drugs Fund Axicabtagene ciloleucel  YESCARTA®
08.01.01 Formulary Cancer Drugs Fund Bendamustine 
08.01.05 Formulary Cancer Drugs Fund Bevacizumab 
08.01.05 Formulary Cancer Drugs Fund Bortezomib Velcade®
08.01.05 Formulary Cancer Drugs Fund Brentuximab vedotin Adcetris®
08.01.05 Formulary Cancer Drugs Fund Cemiplimab 
08.01.05 Formulary Cancer Drugs Fund Cetuximab Erbitux®
08.01.05 Formulary Cancer Drugs Fund Daratumumab Darzalex ®
08.01.05 Formulary Cancer Drugs Fund Dasatinib Sprycel®
08.01.02 Formulary Cancer Drugs Fund Doxorubicin Hydrochloride Lipid formulation
08.01.05 Formulary Cancer Drugs Fund Durvalumab 
08.01.05 Formulary Cancer Drugs Fund Ibrutinib Imbruvica®
08.01.05 Restricted Use Cancer Drugs Fund Ixazomib 
08.02.03 Formulary Cancer Drugs Fund Nivolumab Opdivo®
08.01.05 Formulary Cancer Drugs Fund Osimertinib 
08.01.05 Formulary Cancer Drugs Fund Panitumumab Vectibix®
08.01.05 Formulary Cancer Drugs Fund Pembrolizumab Keytruda®
08.01.03 Formulary Cancer Drugs Fund Pemetrexed Alimta®
16.02 Formulary Cancer Drugs Fund Radium-223 Xofigo®
01.01 Formulary Cancer Drugs Fund Remote Control Panasonic®
08.01.05 Formulary Cancer Drugs Fund Rucaparib Rubraca®
08.01.05 Formulary Cancer Drugs Fund Sorafenib Nexavar®
08.01.05 Formulary Cancer Drugs Fund Sunitinib Sutent®
08.01.05 Formulary Cancer Drugs Fund Temsirolimus Torisel®
08.01.05 Formulary Cancer Drugs Fund Tisagenlecleucel Kymriah®
08.01.05 Formulary Cancer Drugs Fund Venetoclax Venclyxto®
Birmingham, Sandwell, Solihull and environs APC Formulary